SOURCE: Implant Sciences Corporation

Implant Sciences Corporation

September 05, 2012 07:00 ET

Implant Sciences Explosives and Narcotics Trace Detectors to Be Shown at Major European Police Exhibition

Products Featured by Implant Sciences' Distributor D-TeC System Consulting GmbH in Booth E58

WILMINGTON, MA--(Marketwire - Sep 5, 2012) -  Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced that its Quantum Sniffer™ QS-B220 desktop explosives and drugs trace detector and QS-H150 handheld explosives trace detector will be exhibited at the 7th GPEC General Police Equipment Exhibition and Conference®, scheduled for September 11-13, 2012, at the Leipzig Trade Fair Center in Leipzig, Germany. Implant Sciences' equipment will be featured by the Company's German distributor D-TeC System Consulting GmbH in booth E58.

GPEC General Police Equipment Exhibition & Conference is Europe's leading closed specialized trade fair, exclusively held for members of authorities. The focus is on equipment, special technologies, safety technology, and respective services for authorities including police, border guards, customs and financial bodies, prisons, Special Forces, military police, gendarmerie, and infantry. GPEC reaches executives, technicians, procurement officers, instructors, and end users at international, national, and regional levels. Members of parliament responsible for security tasks or budget matters are also admitted.

"Having our products at this important police event builds Implant Sciences' international presence in explosives and drugs trace detection. Our network of distributors around the world, including D-TeC System Consulting, is a critical asset to our Company," stated Implant Sciences' Vice President of Global Sales and Marketing, Dr. Darryl Jones.

D-TeC System Consulting provides a range of products from explosives and drug detection to software solutions for access management, HR applications, and loss and fraud prevention projects. In addition, D-TeC offers consultancy support for seaport and airport-related applications in partnership with experienced risk and crisis management companies as well as holistic security concepts in the industry. For more information, visit D-TeC's website at

About the Quantum Sniffer™ QS-H150 Handheld Explosives Trace Detector

The Quantum Sniffer QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology, providing fast, accurate detection of trace amounts of a wide variety of military, commercial, and homemade explosives. Built with no radioactive materials and featuring a low-maintenance, self-calibrating, and self-clearing design, the QS-H150 provides very high levels of operational availability. The QS-H150 has been proven to perform well in a wide variety of temperatures and challenging environments, from humid jungles to dry, sand swept deserts.

About the Quantum Sniffer™ QS-B220 Desktop Explosives & Drugs Trace Detector

The Quantum Sniffer QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives, as well as drugs. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and internal automatic self-calibration, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use. 

About Implant Sciences

Implant Sciences develops, manufactures and sells sophisticated sensors and systems for Security, Safety, and Defense (SS&D) markets. The Company has developed proprietary technologies used in its commercial explosive and narcotics trace detection systems which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the Company's QS-B220 desktop explosives and drugs trace detector has received a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act). For further details on the Company and its products, please visit the Company's website at

Safe Harbor Statement

This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; our business is subject to intense competition and rapid technological change; the risks that our markets are subject to technological change and that our success depends on our ability to develop and introduce new products; and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.

Contact Information

  • Contact:

    Implant Sciences Corporation
    Company Contact:
    Glenn Bolduc
    Email Contact


    Investor Contact:
    Laurel Moody
    Email Contact